Agios Pharmaceuticals, Inc. (AGIO) NASDAQ

36.45

-0.3329(-0.91%)

Updated at September 15 03:19PM

Currency In USD

Valuation

Market Cap1.87B
Enterprise Value1.85B
P/E Ratio3.25
PEG Ratio-1.58
Price/Sales Ratio51.81
Price/Book Ratio1.54
Enterprise/Revenue51.02
Enterprise/EBITDA-4.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin15.9
Operating Margin-11.29

Management Effectiveness

Return On Assets0.44
Return On Equity0.43

Income Statement

Revenue36.5M
Revenue/Share0.71
Gross Profit32.33M
EBITDA-425.74M
Net Income673.73M
Diluted EPS11.64

Balance Sheet

Total Cash938.94M
Total Cash/Share16.21
Total Debt48.76M
Total Debt/Equity0.04
Current Ratio14.48
Book Value Per Share23.64

Price History

52-Week Change-19.74
52-Week High62.58
52-Week Low23.42
Moving Average 50 Days37.68
Moving Average 200 Days35.12

Statistics

Average Volume810,693
Shares Outstanding58.1M
% Held by Institutions101.6

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A